iShares Global Healthcare ETF (IXJ) seeks to track the S&P Global 1200 Healthcare Sector Index, which measures the performance of healthcare companies across developed markets worldwide including pharmaceuticals, biotechnology, medical devices, and healthcare services providers.
How It Works
IXJ uses a passively managed, market-capitalization-weighted approach that holds healthcare stocks from approximately 23 developed countries. The fund replicates its benchmark by holding all or a representative sample of index constituents, with larger companies like Novo Nordisk and Johnson & Johnson receiving higher allocations. Quarterly rebalancing maintains alignment with index changes and sector classifications.
Key Features
- Provides diversified global healthcare exposure beyond U.S. markets, including European pharmaceutical giants and emerging biotech companies
- Captures defensive characteristics of healthcare sector with historically lower volatility than broader equity markets during downturns
- Offers currency diversification through holdings denominated in euros, Swiss francs, and other developed market currencies
Risks
- This ETF can lose value when regulatory changes threaten drug pricing or healthcare policies, potentially causing 15-25% declines during policy uncertainty periods
- Currency fluctuations can reduce returns when foreign currencies weaken against the dollar, adding volatility beyond underlying stock performance
- Healthcare sector concentration means the fund will underperform during periods when technology or other sectors lead market gains
Who Should Own This
Best suited as a satellite holding (5-15% of equity allocation) for investors with 3+ year time horizons seeking defensive sector exposure and international diversification. Medium risk tolerance required for sector concentration and currency volatility. Appeals to income-focused investors given healthcare's dividend-paying characteristics.